ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,106,578,000 | -31.5% | 27,377 | -2.5% | 0.02% | -24.0% |
| Q2 2015 | $1,615,831,000 | -69.9% | 28,077 | -66.7% | 0.02% | -69.9% |
| Q1 2015 | $5,372,284,000 | -60.0% | 84,377 | -61.2% | 0.08% | -61.8% |
| Q4 2014 | $13,418,263,000 | +54.7% | 217,335 | -2.7% | 0.22% | +43.7% |
| Q3 2014 | $8,672,098,000 | +12.6% | 223,335 | -0.1% | 0.15% | +15.3% |
| Q2 2014 | $7,699,231,000 | +373.9% | 223,490 | +494.4% | 0.13% | +351.7% |
| Q1 2014 | $1,624,696,000 | +6.9% | 37,600 | -1.4% | 0.03% | +3.6% |
| Q4 2013 | $1,519,896,000 | +25.2% | 38,150 | +17.9% | 0.03% | +12.0% |
| Q3 2013 | $1,214,419,000 | +39.3% | 32,350 | -0.3% | 0.02% | +31.6% |
| Q2 2013 | $871,932,000 | – | 32,450 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |